Cited by 654Computational Drug Discovery MethodsMachine Learning in Materials ScienceArtificial Intelligence in Healthcare and Education

Advancing drug discovery via artificial intelligence

Open access
Chan, H.C. Stephen, Shan, Hanbin, Dahoun, Thamani, Vogel, Horst, Yuan, Shuguang·2019·Trends in Pharmacological Sciences

Abstract

Drug discovery and development are among the most important translational science activities that contribute to human health and wellbeing. However, the development of a new drug is a very complex, expensive, and long process which typically costs 2.6 billion USD and takes 12 years on average. How to decrease the costs and speed up new drug discovery has become a challenging and urgent question in industry. Artificial intelligence (AI) combined with new experimental technologies is expected to make the hunt for new pharmaceuticals quicker, cheaper, and more effective. We discuss here emerging applications of AI to improve the drug discovery process.

Integrity signals

Registry

Crossref · 10.1016/j.tips.2019.06.004

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chan, H. C. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S.
Affiliations
  • Chinese Academy of Sciences (CN)
  • Shanghai Institute of Pharmaceutical Industry (CN)
  • École Polytechnique Fédérale de Lausanne (CH)
Corresponding author
Yuan, Shuguang
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2019-08
Volume
40
Issue
8
Pages
592-604
ISSN
0165-6147 (ISSN-L)
OpenAlex
W2962398326
Cited by
654
References
7
Citations by year
2026: 54 · 2025: 94 · 2024: 131 · 2023: 157 · 2022: 82 · 2021: 95 · 2020: 36 · 2019: 5
FWCI
4.53
Type
journal article
Language
en
Update notices
erratum (2019-10-01)
Open access
Locations
  • Trends in Pharmacological Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • Interdisciplinary Centre for Mathematical and Computational Modelling in Warsaw (GB71–3, GB70-3)
  • European Community (FP7-KBBE-2013-613879)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
  • Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
Keywords
artificial intelligence, drug discovery, drug development costs, translational research, pharmaceuticals
MeSH terms
Animals, Artificial Intelligence, Pharmaceutical Preparations, Humans, Pharmacology, Quantitative Structure-Activity Relationship, Drug Discovery, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review